Tumor website：www.tumorsci.org E-mail Alert
Research progress in CDK4/6 inhibitors in neoadjuvant therapy of HR-positive HER2-negative breast cancer
XIAO Hongyan, ZHANG Lina, GU Lin
Tumor . 2022, (12): 835 -844 .  DOI: 10.3781/j.issn.1000-7431.2022.2111-0864

Copyright © Tumor, All Rights Reserved.
E-mail: tumor@tumorsci.org
Powered by Beijing Magtech Co., Ltd.